
Europe Hemodialysis and Peritoneal Dialysis Market
No. of Pages: 123 | Report Code: BMIRE00025826 | Category: Life Sciences
No. of Pages: 123 | Report Code: BMIRE00025826 | Category: Life Sciences
The rising prevalence of diabetes is the major factor driving the Europe hemodialysis and peritoneal dialysis market. Diabetes occurs when blood glucose, also called blood sugar, is too high. High blood glucose can cause health problems over time. The main types of diabetes are type 1, type 2, and gestational. With diabetes, the small blood vessels in the body are injured. When the blood vessels in the kidneys are injured, the kidneys cannot clean the blood properly. The body will retain more water and salt than it should, resulting in weight gain and ankle swelling. Also, waste materials will build up in the blood. Diabetes may also cause damage to nerves in the body, which can cause difficulty emptying the bladder. The pressure resulting from a full bladder can back up and injure the kidneys. According to a study, about 30% of patients with Type 1 (juvenile-onset) diabetes and 10–40% of those with Type 2 (adult-onset) diabetes will eventually suffer from kidney failure. Therefore, an increase in the prevalence of diabetes also increases the chances of dialysis for a patient's survival, thereby fueling the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe hemodialysis and peritoneal dialysis market. The Europe hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.
Strategic insights for the Europe Hemodialysis and Peritoneal Dialysis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 25,140.48 Million |
Market Size by 2028 | US$ 36,242.91 Million |
Global CAGR (2022 - 2028) | 6.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Hemodialysis and Peritoneal Dialysis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country. Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share. Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022. Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022. Based on country, the Europe hemodialysis and peritoneal dialysis market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe. Germany is anticipated to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Diaverum; Fresenius Medical Care AG & Co KGaA; and Nipro Medical Corporation are among the leading companies operating in the Europe hemodialysis and peritoneal dialysis market.
The Europe Hemodialysis and Peritoneal Dialysis Market is valued at US$ 25,140.48 Million in 2022, it is projected to reach US$ 36,242.91 Million by 2028.
As per our report Europe Hemodialysis and Peritoneal Dialysis Market, the market size is valued at US$ 25,140.48 Million in 2022, projecting it to reach US$ 36,242.91 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Europe Hemodialysis and Peritoneal Dialysis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Hemodialysis and Peritoneal Dialysis Market report:
The Europe Hemodialysis and Peritoneal Dialysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Hemodialysis and Peritoneal Dialysis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Hemodialysis and Peritoneal Dialysis Market value chain can benefit from the information contained in a comprehensive market report.